(Q42234975)

English

Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations

scientific article published on 30 December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

2

object named as

P Ljungman

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

4

object named as

J Mattsson

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

O Blennow

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

E Sparrelid

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

M Remberger

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

30 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Transplant Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

106-114

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Allogeneic peripheral blood stem cell transplantation using reduced intensity versus myeloablative conditioning regimens for the treatment of leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1111%2FTID.12175

21 January 2018

Identifiers

10.1111/TID.12175

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42234975&oldid=1937409566"